Opioid Misuse
The drugs contain opioids are substances that are derived from pharmacologically similar to opiates, which includes a strong family of analgesics that carry with important risk of addiction. These opioids are a blessing for the people who have debilitating pain, helps to manage and get back to normal functioning, but in contrast it can destroy the lives of an individual with addiction. Prescription drug misuse has become a nationwide epidemic with deaths quadrupling since 1999 (Centers for Disease Control and Prevention [CDC], 2016).
The objectives for the change is to avoid opioid misuse and to effectively manage opioid risk in patients treated for chronic pain. The proposed articles were reviewed to evaluate various methods available to …show more content…
Hospital admissions associated with opioid related complications, that can even happen with the regular prescribed and “weaker” codeine (McCrorie et al., 2015). Along with patients, most of the practitioners also have dissatisfaction about the way of chronic pain management and they will be more receptive of any new strategies for the management of chronic, non-cancer pain, and opioid prescribing. I have included 5 research articles in the data abstraction and analysis for the project after a comprehensive literature search. Each type of PICOT question has different levels of evidence (Melnyk & Fineout-Overholt, 2015). I have developed an intervention-based question so I have included 2 systemic reviews and 3 qualitative studies, which discusses different ways to identify the opioid misuse and the guidelines for the proper management of opioid prescriptions. The data abstraction is outlined in the matrix including study design, sample, and statistical outcomes. All the studies have pressed the importance about the high risk of prescription overdose-associated death and the significance of adequate monitoring and management. Most of the studies have similar recommendations about practices for reducing the opioid associated risks, despite the inconsistency on development methods, suggesting attention to drug-drug and drug-disease interactions, all features of monitoring, comprising prescription monitoring programs (PMP), urine drug testing, screening tools (to monitor opioid adherence), and development of Abuse Deterrent Formulations (ADF) of opioids
The objectives for the change is to avoid opioid misuse and to effectively manage opioid risk in patients treated for chronic pain. The proposed articles were reviewed to evaluate various methods available to …show more content…
Hospital admissions associated with opioid related complications, that can even happen with the regular prescribed and “weaker” codeine (McCrorie et al., 2015). Along with patients, most of the practitioners also have dissatisfaction about the way of chronic pain management and they will be more receptive of any new strategies for the management of chronic, non-cancer pain, and opioid prescribing. I have included 5 research articles in the data abstraction and analysis for the project after a comprehensive literature search. Each type of PICOT question has different levels of evidence (Melnyk & Fineout-Overholt, 2015). I have developed an intervention-based question so I have included 2 systemic reviews and 3 qualitative studies, which discusses different ways to identify the opioid misuse and the guidelines for the proper management of opioid prescriptions. The data abstraction is outlined in the matrix including study design, sample, and statistical outcomes. All the studies have pressed the importance about the high risk of prescription overdose-associated death and the significance of adequate monitoring and management. Most of the studies have similar recommendations about practices for reducing the opioid associated risks, despite the inconsistency on development methods, suggesting attention to drug-drug and drug-disease interactions, all features of monitoring, comprising prescription monitoring programs (PMP), urine drug testing, screening tools (to monitor opioid adherence), and development of Abuse Deterrent Formulations (ADF) of opioids